支气管动脉msct血管成像的临床应用分析-analysis of clinical application of bronchial artery msct angiography.docx

quadrant， second BAs in 2nd quadrant， Forty-three BAs in the 4th quad-rant. Twenty-secondBAs were from the anterior wall of the descend aorta， fifty-one Bas were from the right wall of the descend aorta， Four BAs were from the posterior wall of the descend aorta，nine Bas were from the left wall of the descend aorta，one Bas were from the right subclavian aorta，one BA was from the left common carotid aorta，one BA was from the right thyrocervical trunk. Conclusion：MSCTA can clearly show the BAs and their origins，and determine the origin of feeding BA， which is of clinical value to provid true and valuable information for BAs originsfor interventional therapy of lung cancer.Key words:Lung cancer；Bronchus artery；volume rendering technique; image merge；X-ray computed.PART3Impact of multi-layer spiral CT angiography of bronchial artery in assessment of the bronchial artery supply to the primary lung cancerAbstract Objective：To investigate the blood supply of primary lung cancer (PLC) using CTangiography for bronchial artery (BA).Methods ： Seventy-five patients under went MSCT angiography per Surestart technique (experimental group, n= 45) (control group, n=30). The setting of spiral CT was 1.25 mm inthickness, 15 in pitch, and 0.5 s/r by scanning speed. CTA was performed using 350 mgI/mL nonionized contrast medium, delivered at a dose of 1.5 mL/kg and at a rate of 3?5 mL/s. Post processing technique such as shaded volume reconstruction,multiplanar reconstruction, curedplanar reconstrution and maximum intensity projection were used to generate the 3D imaging of bronchial artery.Results：One hundred and twenty-two bronchial arteries were visualized of the 45 cases in theexperimental group (mean: 2.71 arteries per case) versus 68 of the 30 cases in the control group (mean: 2.27 arteries per case). The rate of successful visualization and number of visualized arteries were found to be significantly different between the two groups (P0.05).Conclusion ： Primary lung cancer pat